International cooperation discussed at the Drug Safety Forum

In his speech, he emphasized the need to find joint solutions to provide human beings with quality, effective, and safe medicines, “At the same time, GMP experts still need an independent international platform for professional communication and experience exchange. The creation of the Global Association of Pharmaceutical Inspectorates is aimed at leveling the situation that emerged as drug regulatory affairs experts became constrained from their interaction with the global professional community. The Association may also facilitate the export potential development of the GAPI member states.”

Speaking about ensuring the country’s drug safety, Vladislav Shestakov noted that it would impossible without improving the availability of medicines, while mitigation of  regulatory barriers to drug registration and the accelerated introduction of new drugs into the market are among the effective mechanisms for improving drug safety.

Mutual recognition of GMP certificates issued by different countries can contribute to this. Bilateral intergovernmental agreements will facilitate access to the market for medicines from friendly nations, which, in turn, would facilitate both importing and exporting health products.